Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation
Clinical trial NCT06905847 · COMPLETED
Trial details
- NCT number
- NCT06905847
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2025-01-13
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.